Claudio Dagostin

About

Claudio got his PhD in Chemistry (Mechanisms of Organic Reactions) from the University in 2000. He went for a post-doc at Imperial College London where he worked on Alzheimer's disease chemical probes. In 2004, he started working in several companies in the Cambridge biotech cluster where he deepened his knowledge in Medicinal Chemistry and in Fragment Based Drug Design. In 2012 he went back to academia at Cambridge University where he investigated challenging drug targets such as protein-protein interactions. He also co-founded the Entrepreneurial Postdocs of Cambridge (EPOC) society in 2015 to support postdocs in their pursuit of entrepreneurial careers. In 2017 joined Capital Cell and then Abzena in Cambridge with a role in Business Development.

Source (opens in a new tab)